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Interferon-alpha (IFN-a) is a potent suppressor of hepatitis B virus (HBV) replication in the HBV-transgenic mouse, depleting virus
replication intermediates from infected hepatocytes via pathways mediated by interferon-gamma (IFN-g) and tumor necrosis factor alpha
(TNF-a). It has also been hypothesized that cytokines induce curing of infected hepatocytes via non-cytolytic pathways during resolution of
transient hepadnavirus infections. We have therefore evaluated therapy of chronic woodchuck hepatitis virus (WHV) infections using
treatment with the nucleoside analog clevudine [L-FMAU; 1-(2-fluoro-5-methyl-b-L-arabinofuranosyl) uracil] and therapy with adenovirus
vectors expressing INF-g, TNF-a, and beta-galactosidase. Before their use in vivo, expression of IFN-g and TNF-a from the adenovirus
vectors was evaluated in vitro. Conditioned media from adenovirus-infected WC-3 cells was shown to inhibit WHV replication in
baculovirus-transduced cells. Adenovirus super-infection of the liver in woodchucks led to declines in the percentage of hepatocytes with
detectable core antigen and nucleic acids, and in levels of covalently closed circular DNA (cccDNA) and total WHV DNA, but a major long-
term benefit of adenovirus super-infection during clevudine treatment was not demonstrated. Moreover, the effect took at least 2 weeks to
develop suggesting that the declines in the percentage of WHV-infected cells, ccc, and total WHV DNA resulted from induction of the
adaptive immune response by the adenovirus super-infection, and only indirectly from the expression of cytokines by the vectors.
D 2004 Elsevier Inc. All rights reserved.Keywords: Hepatitis B virus; Clevudine; IFN-a
Introduction indirect effects through induction of adaptive immuneAdministration of interferon-alpha (IFN-a) to patients
with chronic HBV infection can cause a transient or perma-
nent suppression of virus replication (Perrillo, 2002; van
Nunen et al., 2001). The mechanism is unclear, though it is
generally believed to involve both direct suppressive effects
on virus replication via stimulation of the innate immune
response and destabilization of viral nucleocapsids as well as0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.06.017
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allison.jilbert@adelaide.edu.au (A.R. Jilbert).responses, with production of virus-specific antibodies and
virus antigen-specific cytotoxic T lymphocytes (CTL). The
long-term efficacy is however, generally low, with only 12–
24% of patients experiencing a permanent suppression in
viral replication accompanied by seroconversion from HBV
e antigen to anti-HBe antibody positive status (Cooksley et
al., 2003). Combination therapy with the nucleoside analog,
lamivudine, and IFN-a has produced only a marginal in-
crease in efficacy. Typically, neither of these regimes results
in elimination of infection as treated patients remain HBsAg-
positive, with reduced levels of virus replication in the liver
and possible sero-conversion to anti-HBe antibodies.
Nucleoside analogs that inhibit hepadnaviral DNA syn-
thesis lead to a decline in levels of replicative intermediate
DNA (RI-DNA) in the cytoplasm of infected hepatocytes
Fig. 1. Inhibition of WHV DNA replication by conditioned media from
WC-3 cells infected with Ad-Wc-IFN-g and Ad-Wc-TNF-a. WC-3 cells
were transduced with baculo-CMVWHV for 1 h at 37 jC. The unabsorbed
baculovirus was removed and conditioned medium from WC-3 cells that
had been infected with the indicated adenovirus vectors, or fresh medium,
was added (lanes 1–4). Alternatively, the cultures received fresh complete
medium during the first 24 h and the conditioned medium was added
beginning 24 post-transduction (lanes 5–7). Cells shown in lane 8 were
harvested 24 h post-transduction. Non-transduced cells maintained in
normal medium are shown in lane 9. Culture fluids were replaced daily and
the cells were harvested at 4 days post-transduction. Cells in lane 8 were
harvested 24 h post-transduction. One quarter of the WHV DNA in viral
nucleocapsids and cccDNA from each dish were analyzed, as shown in the
top and bottom panels, respectively. PDS, partially double-stranded WHV
DNA; SS, 3.3-kb single-stranded DNA.
Fig. 2. Experiment 1. Cytokine mRNA expression detected by RPA
following super-infection of woodchucks with Ad-Wc-IFN-g or Ad-Wc-
TNF-a. Chronically WHV-infected woodchucks were started on therapy
with clevudine and 1 week later were inoculated intravenously with 5 
1012 adenoviruses per kilogram of body weight of Ad-Wc-IFN-g (WC373),
Ad-Wc-TNF-a (WC375), or HHBS buffer as a control (WC376). Liver
biopsies were taken 63 days before therapy (-63) and 1 day after adenovirus
super-infection (day 8) and the woodchucks were autopsied after 7 days
(day 14). Expression of TNF-a, IFN-g, and GAPDH were detected by RPA
as described in Materials and methods.
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replicating circular DNA (cccDNA) (Tuttleman et al., 1986),
the virus transcriptional template found in the hepatocyte
nucleus, is much slower, andmay require death of the infected
cells (Zhu et al., 2001). Early studies revealed that IFN-a
administration also induces a reduction of viral RI-DNA in
the cytoplasm of infected hepatocytes, with less effect on viral
cccDNA (Omata et al., 1986). Subsequent studies with HBV
transgenic mice have revealed that IFN-a production follow-
ing super-infection of a small fraction of hepatocytes with
another virus, LCMV, activated local production of interfer-
on-gamma (IFN-g) and TNF-a, resulting in non-cytocidal
elimination of RI-DNA from the cytoplasm of hepatocytes
within 24 h and viral RNAwithin a few days (Guidotti et al.,
1996a). Similar effects on HBV RI-DNA were produced in
response to super-infection with an adenovirus vector
expressing beta-galactosidase, but a high percentage of ade-
novirus-infected liver cells were needed to produce the effect,
and HBV RI-DNA clearance took a few days longer. Effects
on HBV mRNA levels were not observed. These different
studies have raised the hope that more effective delivery of
cytokines to the liver in HBV patients might significantly
improve the therapeutic response, especially if cytokine-
induced pathways in humans were able to eliminate not just
RI-DNA from the cytoplasm but also the viral cccDNA from
the nucleus of infected hepatocytes. Unfortunately, it has sofar not been possible to analyze the effects of cytokines on
cccDNA in HBV transgenic mice because cccDNA is not
produced in significant amounts in the transgenic mice that
have been studied (Raney et al., 2001).
To determine how the immune response might be manip-
ulated to eliminate cccDNA and resolve a chronic infection,
other studies have focused on transient hepadnavirus infec-
tions. Analysis of hepadnavirus infections in woodchucks
and ducks suggested that a great deal of cell death might
occur during resolution of transient infections by the immune
system, implying that cell death rather than non-cytolytic
processes is a major pathway for virus elimination (Guo et al.,
2000; Jilbert et al., 1992; Kajino et al., 1994; Mason and
Litwin, 2002). In contrast, based on analyses of transient
HBVinfections in chimpanzees, it has been hypothesized that
HBV cccDNA may be cleared without hepatocyte death
through the action of cytokines (Guidotti et al., 1999;
Thimme et al., 2003). However CD8+ T cells were required
to clear the infection (Thimme et al., 2003), which could
reflect either a requirement for cell killing or for cytokine
production by CD8+ T cells that are in contact with infected
hepatocytes (Slifka et al., 1999). A recent analysis of transient
woodchuck hepatitis virus (WHV) infection in woodchucks
indicated that the number of hepatocytes destroyed during
resolution of an infection probably exceeds the initial number
of infected cells (Summers et al., 2003). Newly recognized
histologic evidence for extensive cell death in the liver also
supports this view (Jilbert et al., unpublished observations).
Thus, while RI-DNA is clearly lost or diminished in abun-
dance through the action of cytokines in HBV transgenic
mice and probably in natural infections as well (Omata et al.,
1986; Thimme et al., 2003), it remains unclear from analyses
of chronic and transient infections if cytokines are able to
clear cccDNA from infected cells. Alternatively, cell killing
by HBV antigen-specific CTL may be the major route for
Fig. 3. Experiment 1. Cytokine mRNA expression detected by quantitative
RT-PCR following super-infection of woodchucks with Ad-Wc-IFN-g or
Ad-Wc-TNF-a. Woodchucks were treated with clevudine and after 1 week
were infected with Ad-Wc-IFN-g, Ad-Wc-TNF-a, or HBSS buffer as a
control, and liver biopsied as described in the legend to Fig. 2. Levels of
TNF-a, IFN-g, 5VOAS, and CD8 RNA were determined by real time RT-
PCR as described in Materials and methods, and are expressed as ratios of
the respective RNA copy number to that of GAPDH, which served as a
control.
Fig. 4. Experiment 1. WHV RI-DNA in the liver of woodchucks infected
with Ad-Wc-IFN-g or Ad-Wc-TNF-a. Woodchucks were treated with
clevudine and after 1 week were infected with the indicated adenovirus or
with HBSS as a control, and liver biopsies were collected as described in
the legend to Fig. 2. Total WHV DNA was extracted and analyzed by
Southern hybridization on 1.5% agarose gels as described in Materials and
methods. The location of 3.3-kb linear viral DNA (SS) and 3.3-kb double-
stranded linear viral DNA are indicated. RI, RI-DNA.
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cytokine-induced pathways may have another role, such as
blocking formation of the nuclear cccDNA from viral RI-
DNA present in mature nucleocapsids in the cytoplasm. If
this were so, induced destruction of hepatocytes might be a
major facilitator of antiviral therapy of chronic infections
(Fourel et al., 1994).
Recently, we investigated if super-infection of WHV-
infected woodchucks with an adenovirus, expressing beta-
galactosidase, could reduce levels of WHV replication (Zhou
et al., 2000). In particular, we looked for evidence that the
adenovirus super-infection would facilitate WHV clearance
via non-cytolytic pathways (Cavanaugh et al., 1998), as well
as via cell death produced by the CTL response to the vector.
Adenovirus super-infection was carried out 6 months afterinitiation of continuous antiviral therapy with lamivudine.
Lamivudine by itself has low efficacy against chronic WHV
infection, possibly because of inefficient phosphorylation in
woodchuck liver, and typically suppresses virus levels in the
serum only about 100-fold before drug-resistant variants
emerge (Mason et al., 1998a; Tatti et al., 2002; Zhou et al.,
1999). Within 2 weeks of adenovirus super-infection, a 2- to
4-fold loss of cccDNAwas observed which correlated with a
decline in cells expressing beta-galactosidase, consistent with
loss of adenovirus-infected cells via CTL destruction (Yang
et al., 1994b). At the same time, a 10- to 20-fold decline in RI-
DNAwas observed, which may have been due to the effects
of cytokines on formation of RI-DNA (Zhou et al., 2000).
Beginning approximately 1–2 months post-adenovirus su-
per-infection, WHV levels in the serum showed an additional
decline, to 1000-fold or more below pre-treatment levels,
even when prior emergence of a lamivudine-resistant WHV
variants had been detected. This suppression was, however,
temporary, and WHV levels began to rebound within 3
months (Zhou et al., 2000). Thus, in this study, the immune
response to the adenovirus infection did not eliminate
cccDNA. However, it was possible that more significant
effects on cccDNA survival might have beenmasked because
of the limited activity of lamivudine against WHV (Mason et
al., 1998a), as well as the presence of lamivudine-resistant
variants of WHV, which may have allowed new cccDNA
synthesis to occur from existing RI-DNA. A basis for the
delayed drop in WHV levels was not determined.
In the present study, we have used recombinant adenovirus
vectors expressing woodchuck IFN-g and tumor necrosis
factor alpha (TNF-a) to investigate effects on WHV replica-
tion in cell culture and in chronically WHV-infected wood-
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agent, clevudine [L-FMAU; 1-(2-fluoro-5-methyl-b-L-arabi-
nofuranosyl) uracil] to inhibit WHV DNA synthesis during
super-infection with the different vectors (Peek et al., 2001;
Zhu et al., 2001). Our results suggested that either directly or
indirectly, IFN-g and TNF-a expression in cell culture leads
to an antiviral activity that blocks an early step in the
formation of viral replication complexes and RI-DNA, as
previously reported for HBV and duck hepatitis B virus
(DHBV) producing cells exposed to IFN-g or IFN-a (Pas-
quetto et al., 2002; Schultz and Chisari, 1999). In vivo, the
data suggest that IFN-g and TNF-amay also block formation
of viral replication complexes and facilitate elimination of RI-
DNA from WHV-infected hepatocytes when used in combi-
nation with clevudine. However, the long-term effects on
WHV infection, including elimination of RI-DNA and
cccDNA and a reduction in infected hepatocytes, did not
improve on treatment with clevudine alone.Results
Inhibition of WHV DNA replication in vitro by conditioned
media from adenovirus-infected WC-3 cells
cDNA clones containing the IFN-g and TNF-a genes of
the woodchuck were previously described (Guo et al.,
2000). To determine if these cDNAs encoded biologically
active proteins, WC-3 woodchuck hepatoma cells (Lee et
al., 1987) were infected with recombinant adenovirus vec-
tors expressing Wc-IFN-g and Wc-TNF-a (Ad-Wc-IFN-g
and Ad-Wc-TNF-a), or an adenovirus vector expressing
beta-galactosidase (Ad-beta-galactosidase) (Yang et al.,
1994a; Zhou et al., 2000) that served as a control. Culture
medium from WC-3 cells infected with the Ad-Wc-IFN-g
expression vector was tested for antiviral activity against theTable 1
Experiment 1
Woodchuck Treatment Clevudine
treatment (days)
373f Clevudine + Ad-Wc-IFN-g 63b
8c
14d
375m Clevudine + Ad-Wc-TNF-a 63b
8c
376f Clevudine + HBSS 63b
8c
14d
The effect of antiviral treatment with clevudine followed 1 week later by super-in
WHV infection.
a The percentage of PCNA-positive hepatocytes and the number of CD3-positive
fields at 400. The number of CD3-positive liver cells is expressed as a ratio pe
b Woodchucks chronically infected with WHV were biopsied 63 days before init
with the indicated adenovirus, or injected with HBSS buffer, after 7 days of clev
c Liver biopsies were performed 1 day after adenovirus super-infection on day 8. W
shock from systemic production of TNF-a.
d WC 373 and 376 were euthanized 7 days after the adenovirus super-infection oIndiana strain of vesicular stomatitis virus (VSV) in WC-3
cells (data not shown). The cytotoxic effects of VSV
infection were blocked at a dilution of 1:4, but not at higher
dilutions, suggesting that the expressed protein was biolog-
ically active. The low protective activity was due to a lack of
efficient killing of WC-3 cells by VSV in our assays, thus
limiting the ability to observe a protective effect. No anti-
VSV activity was observed using conditioned medium from
the WC-3 cells infected with the Ad-beta-galactosidase
expression vector. To test for TNF-a released into the
medium of WC-3 cells infected with the Ad-Wc-TNF-a
vector, cytotoxicity of the conditioned medium was mea-
sured on mouse L929 cells (data not shown). Cell killing
was observed out to a dilution of 1:10000. Thus, both
adenovirus vectors, Ad-Wc-IFN-g and Ad-Wc-TNF-a,
appeared to express biologically active cytokines.
Conditioned media from WC-3 cells were then used to
treat WC-3 cells transduced with a baculovirus (baculo-
CMVWHV) expressing WHV pregenomic RNA. As
shown in Fig. 1, lanes 1–4, conditioned medium from
cells infected with Ad-Wc-IFN-g inhibited accumulation
of WHV RI-DNA 20-fold compared to the control (lane
4). An 8-fold inhibition of RI-DNA was detected with
medium from cells infected with Ad-Wc-TNF-a, and an
approximately 2-fold effect with medium from Ad-beta-
galactosidase-infected cells. Parallel effects were seen on
accumulation of cccDNA early in infection. The amount of
cccDNA produced following infection with the baculovi-
rus vector was reduced >10-fold in the presence of
conditioned medium from WC-3 cells infected with the
Ad-Wc-IFN-g vector, approximately 10-fold by Ad-Wc-
TNF-a, and 2.5-fold with culture fluids from WC-3 cells
infected with the Ad-beta-galactosidase vector. As found
using a baculo-CMVGFP vector, none of the conditioned
media lowered the efficiency of baculovirus infection of
the WC-3 cells (data not shown).WHcAg-positive
hepatocytes
PCNA-positive
hepatocytesa
CD3-positive cells
per 100 hepatocytesa
>95 0.3 17.5
49 0.6 17.7
70 0.7 21
>95 0.4 13.6
>95 1.7 8.5
>95 0.5 11.4
96 0.5 13.1
92 0.3 16.4
fection with Ad-Wc-IFN-g or Ad-Wc-TNF-a in woodchucks with chronic
cells were determined using a microscope eyepiece grid and scanning 100
r 100 hepatocytes.
iating treatment with clevudine. All three woodchucks were super-infected
udine treatment.
oodchuck 375 died a few hours after the liver biopsy, apparently from toxic
n day 14 of the study.
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IFN-g- or Ad-Wc-TNF-a-infected cells was delayed for 24 h,
a much smaller effect was observed (Fig. 1, lanes 5–7). RI-
DNA accumulation was reduced 25% by conditioned medi-
um from cells infected with the Ad-beta-galactosidase vector,
and 50% by conditioned media from the other two cultures.
For comparison, only 25% of the amount of RI-DNA
observed at 4 days post-transduction was present at 24 h (lane
8). Thus, some accumulation of RI-DNA still occurred in the
presence of the conditioned media from the Ad-Wc-IFN-g-
and Ad-Wc-TNF-a-infected cells. Parallel results were
obtained when cccDNA levels were examined (Fig. 1).Table 2
Experiment 2
Woodchuck Treatmenta Liver
biopsy
(week)b
Percent initial
cccDNA per
liver cellc
Percent initial
RI-DNA per
liver cell 3V
end (5Vend of
minus strand)c
359f Clevudine + 3 100 (68) 100
Ad-Beta-gal 6 0.1 0.005 (0.15)
11 0.08 0.08 (0.06)
48 0.8 0.03 (0.01)
371f Clevudine + 3 100 (66) 100
Ad-Beta-gal 6 4 0.8 (5)
11 0.3 0.05 (0.03)
52 0.13 0.05 (0.01)
363m Clevudine + 3 100 (66) 100
Ad-Beta-gal 6 4 0.7 (15)
11 0.1 0.07 (0.06)
52 0.03 0.02 (0.01)
367f Clevudine + 3 100 (16) 100
Ad-Wc-TNFa/IFNg 52 0.4 0.02 (0.01)
366m Clevudine + 3 100 [11.5] 100
Ad-Wc-TNFa/IFNg 6 54 0.8 (9)
11 13 0.3 (8)
52 2.6 0.02 (.01)
368m Clevudine + 3 100 (113) 100
Ad-Wc-TNFa/IFNg 6 1 0.4 (5)
11 1.5 0.06 (0.1)
22 1 0.04 (0.02)
362f Clevudine + 3 100 (14) 100
HBSS 6 0.9 0.2 (0.7)
11 0.6 0.08 (0.07)
52 ND ND
369f Clevudine + 3 100 (64) 100
HBSS 6 50 0.5 (25)
11 29 1 (25)
19 57 0.5 (4)
370f Clevudine + 3 100 (6) 100
HBSS 6 11 3.8 (14)
11 4 1.8 (1.4)
33 10 0.2 (0.07)
365m Clevudine + 3 100 (49) 100
HBSS 6 38 0.6 (18)
11 59 0.4 (11)
34 2.7 0.09 (0.03)
372m Clevudine + 3 100 (25) 100
HBSS 6 150 6 (97)
11 43 1 (30)
52 0.5 0.01 (0.01)Northern blot analysis (not shown) revealed a similar
pattern of effects on levels of 3-kb viral RNA as observed
with viral DNAs. The only major inhibition (approximately
10-fold) occurred when culture fluids from WC-3 cells
infected with the Ad-Wc-IFN-g or Ad-Wc-TNF-a vectors
were added immediately after adsorption of the WHV-
expressing baculovirus. In brief, factors released by cells
infected with either Ad-Wc-IFN-g or Ad-Wc-TNF-a vec-
tors produced effects on accumulation of viral DNA that
phenotypically resembled those seen in experiments with
DHBV-infected duck hepatocyte cultures treated with either
IFN-g or -a. These effects were proposed to reflect inhibi-In situ
hybridization-
positive
hepatocytes
WHcAg-
positive
hepatocytes
PCNA-
positive
hepatocytesd
CD3-positive
liver cells
per 100
hepatocytesd
Liver
injurye
>95 95 1.22 15.1 1
2.6 24 0.8 18.2 1
0.82 13 0.1 16.2 +/
NDf 0.02 0.5 6.2 ND
>95 98 0.7 15 +/
17.3 12g 6.9 17.7 +/
5.7 3.3h 0.5 13.3 1
ND <0.01 f0.1 11.9 ND
>95 99 0.5 7.3 1
41 46 0.2 7.4 2
1.7 ND f0.03 10.8 +/
ND <0.01 f0.09 13.1 ND
>95 >95 4.1 6.2 ND
ND <0.01 0.3 5.4 ND
95 68 7 7.4 +/
45 35 0.7 5.1 1
35 23 f0.01 11.1 0
ND 0.1 <0.01 16.8 ND
95 95 0.6 15.3 1
42 31 0.9 19.5 1
0.73 2.4i f0.06 4.2 1
ND <0.01 f0.05 13.1 ND
>95 94 0.2 13.8 1
0.04 5g f0.06 12.2 2
10.3 11g 1.4 17.3 +/
ND <0.01 ND ND ND
>95 >95 0.4 16.9 1
20 83 0.09 16.7 +/
49 31 0.1 17.3 1
ND f50 0.4 9.5 ND
>95 99 6 13 1
4 13 1.9 11.5 1
4.4 4 f0.01 9.2 +/
ND <0.01 0.4 20.7 ND
>95 99 0.06 19.7 +/
85 89 0.8 32.1 +/
43 25 f0.07 27.4 +/
ND 1.4 0.7 11.7 ND
>95 95 1.1 13.2 1
75 72 0.2 23.2 +/
25 20 0.7 32.5 1
ND 1 positive cell
per section
f0.03 10.4 ND
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complexes and RI-DNA (Pasquetto et al., 2002; Schultz
and Chisari, 1999; Schultz et al., 1999).
Experiment 1. The effect of antiviral treatment with
clevudine followed 1 week later by super-infection with
Ad-Wc-IFN-c or Ad-Wc-TNF-a in woodchucks with chronic
WHV infection
IFN-g and TNF-a expression in HBV transgenic mice
induces a rapid loss of RI-DNA from hepatocytes, gener-
ally within 24 h (Guidotti et al., 1996b). To determine if
such an effect occurs in a model of natural infection, three
woodchucks (WC373, WC375, WC376) chronically
infected with WHV were treated with clevudine (10 mg/
kg daily) to block new viral DNA synthesis (Zhu et al.,
2001). After 1 week, two woodchucks (WC373, WC375)
were super-infected by intravenous inoculation with 5 
1012 recombinant adenoviruses per kilogram of body
weight while the third woodchuck was inoculated with
HBSS (WC376). Liver biopsies were taken 24 h later and
one woodchuck (WC375), super-infected with the Ad-Wc-
TNF-a vector, died postsurgery, apparently from toxic
shock caused by TNF-a. The remaining two animals
(WC373, WC376) were sacrificed after 1 week. Both the
Ad-Wc-IFN-g and Ad-Wc-TNF-a vectors also contained
the GFP gene and GFP expression was detected in liver at
24 h post-inoculation in approximately 3% and 50% of
liver cells, respectively, suggesting that hepatic super-
infection and/or expression from the Ad-Wc-TNF-a vector
was more efficient. Quantitative PCR (qPCR) detected
0.05 and 2.7 copies of adenovirus DNA per liver cell 24
h after super-infection with the Ad-Wc-IFN-g and Ad-Wc-
TNF-a vectors, respectively. The amount of adenovirus
DNA in the liver of WC373 super-infected with the Ad-Notes to Table 2:
The effect of antiviral treatment with clevudine followed 5 weeks later by su
galactosidase or inoculation with HBSS in woodchucks with chronic WHV infec
a Clevudine was administered to adult woodchucks chronically infected with W
vectors, or with HBSS as a control, was done after 5 weeks of clevudine treatmen
weight.
b Liver biopsies were performed before treatment and again at the indicated num
c With the exception of woodchuck 366, where cccDNA levels were quantified b
determined by qPCR on total and cccDNA enriched fractions, respectively. The st
are shown in parentheses. Two primer sets were used to quantify total DNA as des
region of the minus strand of WHV DNA are shown, with results using primers
parentheses. Molecule numbers before therapy using the 3Vspecific primer set ran
using the 5Vprimer set. Copy numbers of RI-DNA using Southern blot analysis, w
set but were typically about 5- to 10-fold lower, apparently because the copy numb
genomes.
d The percentage of PCNA-positive hepatocytes and the number of CD3-positive
fields at 400. The number of CD3-positive liver cells is expressed as a ratio pe
e The criteria used for assessing liver injury are described in Materials and metho
found at autopsy (final sample described) in all woodchucks except 365 and 367
f Core antigen-positive hepatocytes were mostly present in clusters rather than s
g Core antigen- positive hepatocytes present in clusters and scattered among neg
h Core antigen-positive hepatocytes were mostly present in clusters; abundant ap
i ND = not done.Wc-IFN-g had not changed after 1 week. IFN-g and TNF-
a mRNA were detected in liver tissue by RNase protection
assay (RPA; Fig. 2) and by quantitative RT-PCR (Fig. 3).
As shown (Figs. 2 and 3), expression of each cytokine was
increased approximately 3- to 10-fold by 24 h after ade-
novirus super-infection. RI-DNA was not rapidly cleared
because of the adenovirus super-infection (Fig. 4). More-
over, though core antigen staining appeared to be reduced
in intensity, a significant reduction in the fraction of core
antigen-positive hepatocytes was not observed in WC373
even 1 week after super-infection with Ad-Wc-IFN-g, and
only a modest influx of CD3+ lymphocytes was evident
(Table 1).
Experiment 2. The effect of antiviral treatment with
clevudine followed 5 weeks later by super-infection with
Ad-Wc-IFN-c plus Ad-Wc-TNF-a or Ad-beta-galactosidase
in woodchucks with chronic WHV infection
In an effort to generate a stronger anti-WHV effect using
the adenovirus vectors, we examined the consequences of
inoculating a mixture of both Ad-Wc-IFN-g and Ad-Wc-
TNF-a into woodchucks that had received a total of 5 weeks
of clevudine treatment. Liver biopsies were carried out 1 and
6 weeks after adenovirus super-infection. As summarized in
Table 2, a significant decline in the levels of ccc and RI-DNA
and in the percentage of virus nucleic acid and core antigen-
positive hepatocytes was obtained during treatment with
clevudine plus HBSS. On average, some additional (4-fold)
loss of WHV RI-DNA occurred as a result of super-infection
with either the mixture of Ad-Wc-IFN-g and Ad-Wc-TNF-a
or the adenovirus vector expressing beta-galactosidase, as
assessed by qPCR, and a similar (4-fold) excess loss of
cccDNA had also occurred. No differences were apparent,
however, between woodchucks that received the combina-per-infection with either Ad-Wc-IFN-g plus Ad-Wc-TNF-a or Ad-beta
tion.
HV for a total of 38 weeks. Super-infection with the indicated adenovirus
t. The dose of individual adenoviruses was 5  1012 per kilogram of body
ber of weeks after initiation of clevudine treatment.
y Southern blot analysis, levels of cccDNA and RI-DNA per liver cell were
arting level of cccDNA in copies per liver cell, as determined by Southern,
cribed in Materials and methods. Results with primers specific to the 3Vend
specific for detection of the 5Vend of the minus strand of WHV DNA in
ged from 500 to 2000 per liver cell, compared to 2000–5000 per liver cell
here detectable, generally followed the changes obtained with the 3Vprimer
er by Southern blot analysis is determined in equivalents of full-length viral
cells were determined using a microscope eyepiece grid and scanning 100
r 100 hepatocytes.
ds. This assessment includes nontumorous portions of the liver. HCC was
.
cattered hepatocytes.
ative hepatocytes.
optosis.
Y. Zhu et al. / Virology 327 (2004) 26–4032tion of Ad-Wc-IFN-g and Ad-Wc-TNF-a or Ad-beta-galac-
tosidase. Thus, the consequence on WHV infection 1 week
after adenovirus super-infection appeared to be minor and
was not enhanced by super-infection with the Ad-Wc-IFN-g
and Ad-Wc-TNF-a vectors when compared to super-infec-
tion with Ad-beta-galactosidase alone. This difference be-
tween the groups that either were or were not super-infected
increased to about 10-fold after 6 weeks (11 weeks after
initiation of clevudine therapy) and was still apparent at theTable 3
Experiment 3
Woodchuck Treatmenta Liver
biopsy
(week)b
cccDNA per
liver cell 3V
end
Percent initial
RI-DNA per
liver cellc (5Vend
of minus strand)c
In situ
hybrid
positiv
hepato
347m Clevudine + 4 100 (2.4) 100 >95
TNF-a/IFN-g 2 54 2 (3) 19
6 0.3 0.02 (0.02) 0.9
13 0.4 0.008 (0.005) 0.5
33 <5 <1 0.3
349m Clevudine + 4 100 (10) 100 >95
TNF-a/IFN-g 2 25 5 (24) 22
6 0.3 0.07 (0.04) 0.03
13 0.6 0.05 (0.08) 0.07
33 9 62 38
65 14 96 ND
351m Clevudine + 4 100 100 >95
HBSS 2 79 35 >95
6 68 23 51
13 36 13 50
33 31 71 >95
354f Clevudine + 4 100 100 >95
HBSS 2 48 19 85
6 19 5 33
13 0.6 0.4 0.2
33 16 72 >95
357m Clevudine + 4 100 (20) 100 >95
HBSS 2 22 7 (33) 92
6 5 0.1 (1.6) 10
13 0.09 0.01 (0.02) 0.01
33 1.5 1.7 0.1
52 16 93 ND
The effect of antiviral treatment with clevudine followed 4 weeks later by super-in
with chronic WHV infection.
a Adult woodchucks chronically infected with WHV were started on clevudine trea
the woodchucks were super-infected after 4 weeks of clevudine treatment with a m
kg body weight.
b Liver biopsies were collected at the indicated times and tissue sections were p
hybridization and for detection of core antigen- and PCNA-positive hepatocytes
positive hepatocyte counts were obtained by scanning 100 microscope fields at 4
c The percentage of the initial amount of viral cccDNA and RI-DNA in liver and v
and are shown as percentage of initial value. The initial amount of cccDNA in c
Quantitative PCR (qPCR) was used to quantify cccDNA and RI-DNA for the fi
preparations, the remaining samples were quantified by Southern blot analysis. Re
DNA are shown, with results using primers specific for detection of the 5Vend reg
DNA by qqPCR before therapy were about 500 copies per liver cell using primers
1000 to 1600 using the primer set specific to the 5Vend of the minus strand of W
d The criteria used for assessing liver injury are described in Materials and metho
woodchucks 354 and 357 at the final time point.
e Liver tissue from woodchucks 347 and 349 at 6 weeks had a characteristic patte
earlier biopsies or in any of the other animals. Vacuoles had ragged irregular outlin
stains were not performed.end of the study (Table 2). Interestingly, rebound of viremia
did not occur in any of the woodchucks that were followed
for a further 14 weeks after stopping clevudine treatment (at
38 weeks) and before termination of the study (not shown);
however, a few core antigen-positive hepatocytes were
detected in the liver of some woodchucks at the end of the
study (Table 2), indicating along with the qPCR assays for
viral DNAs, particularly cccDNA, that the infection had not
cleared.ization-
e
cytes
WHcAg -
positive
hepatocytes
PCNA -
positive
hepatocytes
CD3-positive
cells per 100
hepatocytes
Serum virus
titer (109
per ml)c
Liver
injuryd
>95 0.3 43 2.1 2
66 1.4 36 <0.01 1
<0.1 1.1 49 <0.01 1e
<0.1 0.5 22 <0.01 +/
<0.1 f0.02 15 <0.01 +/
>95 0.5 25 3.7 2
45 0.6 25 <0.01 2
0.3 0.4 11.9 <0.01 0
2.5 0.6 14.4 <0.01 0
>95 f0.04 16 ND +/
>90 1.3 25 ND +/
>95 0.09 14 1.9 +/
>95 0.3 15.5 <0.01 +/
91 0.2 8.8 <0.01 +/1
59 0.3 19.5 <0.01 1
>95 f0.01 8.6 ND ND
>95 0.4 16 1.5 1
>95 0.9 26 <0.01 1
83 1.0 27 <0.01 1
7 0.2 22 <0.01 +/
>95 0.2 22.7 ND 2
>95 0.7 33 1.2 1
>95 1.9 28 <0.01 2
51 0.6 29 <0.01 +/
<0.1 0.2 13.6 <0.01 1
<0.1 f0.04 12 ND 1
>90 0.5 18.1 ND ND
fection with a mixture of Ad-Wc-IFN-g and Ad-Wc-TNF-a in woodchucks
tment at 0 weeks. Treatment continued for the next 13 weeks. As indicated,
ixture of Ad-Wc-IFN-g and Ad-Wc-TNF-a, each at a dose of 5  1012 per
rocessed for detection of viral nucleic acid positive hepatocytes by in situ
as well as CD3-positive liver cells by immunoperoxidase staining. PCNA-
00; that is, a minimum of 10000 hepatocytes.
irus titers in serum were determined as described in Materials and methods,
opies per liver cell, as determined by Southern, are shown in parentheses.
rst four time points from woodchucks 347, 349, and 357 using total DNA
sults with primers specific to the 3Vend region of the minus strand of WHV
ion of the minus strand of WHV DNA in parentheses. Copy numbers of RI-
specific for the 3Vend of the minus strand of WHV DNA and ranged from
HV DNA.
ds and include only nontumorous portions of the liver. HCC was found in
rn of diffuse vacuolization of virtually all hepatocytes that was not seen in
es more characteristic of glycogen accumulation than lipid, although special
logy 327 (2004) 26–40 33Experiment 3. The effect of antiviral treatment with
clevudine followed 4 weeks later by super-infection with a
mixture of Ad-Wc-IFN-c and Ad-Wc-TNF-a or treatment
with HBSS in woodchucks with chronic WHV infection
In our previous study (Zhou et al., 2000) in woodchucks
treated with lamivudine and super-infected with an adeno-
virus vector expressing beta-galactosidase, we found a 10-
to 20-fold loss of RI-DNA and a 2- to 3-fold loss of
cccDNA by 2 weeks post-super-infection. This may have
been due to immune destruction of hepatocytes super-
Y. Zhu et al. / ViroFig. 5. Experiment 3. Decline in the fraction of hepatocytes in the liver of woodchu
after adenovirus super-infection. Woodchuck 347 was started on clevudine treatme
and TNF-a 2 weeks after the commencement of clevudine treatment as described in
treatment (A, E), and at weeks 2 (B, F), 6 (C, G), and 13 (D, H) after clevudine tre
D) and for immunoperoxidase staining with rabbit anti-recombinant WHV core
counterstained with hematoxylin. Final magnification 160 (Scale bar = 100 AMinfected with the adenovirus vector, as the host response
to this vector peaked between 1 and 2 weeks post-super-
infection (Zhou et al., 2000).
To determine if the effects of super-infection by the
cytokine expression vectors were greater or qualitatively
different after 2 weeks than 1 week (Table 2), woodchucks
were treated with clevudine for 4 weeks, then inoculated
with a mixture of Ad-Wc-IFN-g and Ad-Wc-TNF-a or
treated with HBSS, and liver tissue was collected at 6
weeks (2 weeks after adenovirus super-infection: Table 3).
Assay of liver extracts for WHV RI-DNA (Table 3) did notck 347 containing detectable levels of WHV nucleic acids and core antigen
nt (time 0) and inoculated with recombinant adenoviruses expressing IFN-g
Table 3. Ethanol acetic acid-fixed tissue sections collected before clevudine
atment were used for in situ hybridization to detect WHV nucleic acids (A–
antigen (E–H) as described in Materials and methods. All panels were
).
Y. Zhu et al. / Virology 327 (2004) 26–4034reveal a difference clearly attributable to super-infection
with the Ad-Wc-IFN-g and Ad-Wc-TNF-a vectors; in
particular, the decline of total WHV DNA levels in wood-
chucks 347 and 349 at 6 weeks (2 weeks after adenovirus
super-infection) was similar to the decline in woodchuck
357, which received clevudine plus HBSS. Analysis of
WHV infection levels by in situ hybridization of liver
sections for detection of viral nucleic acids and staining
for WHV core antigen (Table 3; Figs. 5, 6) revealed, in
contrast, a significant decrease in the percentage of WHV-
positive cells by 6 weeks (2 weeks after Ad-Wc-IFN-g and
Ad-Wc-TNF-a super-infection). Because core protein is aFig. 6. Experiment 3. Decline in the fraction of hepatocytes in the liver of woodch
treatment with clevudine and HBSS. Woodchuck 351 was treated with clevudine
collected before treatment (A, E), and at weeks 2 (B, F), 6 (C, G) and 13 (D, H) a
nucleic acids (A–D) and for immunoperoxidase staining with rabbit anti-recombi
panels were counterstained with Hematoxylin. Final magnification  160 (Scalemajor component of viral replication complexes, this result
was consistent with a cytokine-mediated loss of immature
nucleocapsids containing viral pregenomic RNA and RI-
DNA. As shown in Table 3, the decline in cccDNA in
woodchucks 347 and 349 at 6 weeks exceeded that in WC
357 by approximately 10-fold, to about 0.01 copies per
hepatocyte, also indicating that cells containing cccDNA
were removed from the liver. This difference, similar to that
seen by 6 weeks post adenovirus super-infection in Table 2,
did not appear to be due to a high pre-adenovirus infection
level of infiltration with CD3-positive lymphocytes and
hepatocyte proliferation (PCNA staining) in these wood-uck 351 containing detectable levels of nucleic acids and core antigen after
and HBSS as described in Table 3. Ethanol acetic acid-fixed tissue sections
fter clevudine treatment were used for in situ hybridization to detect WHV
nant WHV core antigen (E–H) as described in Materials and methods. All
bar = 100 AM).
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also exhibited high levels of infiltration and PCNA staining
(Table 3). Clevudine treatment was stopped after 13 weeks,
and WHV infection ultimately rebounded within 1.5–6
months in all woodchucks that were followed. Thus, the
loss of cccDNA following adenovirus super-infection,
though significant, was incomplete.Table 4
Time course of loss of adenovirus DNA from the liver of woodchucks from
experiment 2: woodchucks were treated with clevudine for 5 weeks and
then super-infected with either Ad-Wc-IFN-g plus Ad-Wc-TNF-a or Ad-
beta galactosidase
Woodchuck Treatment Liver biopsy
(week)a
Copies/
cellb
Percent of
initial valuec
359f Clevudine + 3 < 0.004 0
Ad-Beta-gal 6 3.2 100
11 1.5 48
48 0.02 0.7
371f Clevudine + 3 < 0.003 0
Ad-Beta-gal 6 3.5 100
11 2.3 65
52 0.3 9
363m Clevudine + 3 < 0.003 0
Ad-Beta-gal 6 1.45 100
11 2.3 161
52 0.09 6
367f Clevudine + 3 < 0.008 0
Ad-Wc-TNFa/IFNg 52 0.03 1.4
366m Clevudine + 3 0.000 0
Ad-Wc-TNFa/IFNg 6 0.014 0.6
11 0.04 1.6
52 0.003 0.1
368 Clevudine + 3 0.000 0
Ad-Wc-TNFa/IFNg 6 0.08 3.2
11 0.024 1
22 0.007 0.3
a Clevudine was administered to woodchucks chronically infected with
WHV as described in Table 2. Inoculation with the indicated adenovirus
vectors was performed after 5 weeks of clevudine treatment. The dose of
each adenovirus inoculated was 5  1012 per kilogram of body weight.
b Adenovirus DNA was detected by qPCR as described in Materials and
methods and is expressed as copies per total liver cell.
c The percentage of remaining adenovirus DNA for woodchucks 366, 367,
and 368 was calculated assuming that each liver cell contained 2.5 copies of
adenovirus DNA at 1 day post-super-infection (as determined for WC 373
in experiment 1). The percentage for the remainder was assumed to be 100
at 1 week post-super-infection.Discussion
A major deficiency in the use of nucleoside analog
inhibitors to treat chronic HBV infections is the lengthy
time needed to eliminate viral cccDNA. Several recent
studies suggest that cccDNA is stable in infected hepato-
cytes and that loss requires cell death (Summers et al., 2003;
Zhang and Summers, 2000; Zhu et al., 2001). The role of
cell proliferation in cccDNA survival is less clear, as one in
vivo study suggests that cccDNA survives cell division (Zhu
et al., 2001), while studies of proliferating cells in culture
have given conflicting results (Dandri et al., 2000; Guo et
al., 2003). Complete virus loss may therefore take several
complete turnovers of the hepatocyte population, even in the
absence of drug-resistant variants in the infecting virus pool.
Thus, any single nucleoside may be unable to facilitate virus
elimination unless other factors such as the adaptive im-
mune response of the host control infection when virus
replication levels are suppressed.
Recent studies with HBV transgenic mice raised the
possibility of non-cytolytic clearance of virus, which
seemed consistent with initial studies of HBV clearance
during acute infection of chimpanzees (Guidotti et al.,
1999). However, CD8+ T cells were needed for the resolu-
tion of transient infections (Thimme et al., 2003), leaving
open the possibility that hepatocyte death is a key compo-
nent in the resolution of hepadnavirus infection. More recent
experiments with acutely infected woodchucks have shown
that resolution is associated with at least one liver equivalent
of hepatocyte destruction (Summers et al., 2003). However,
none of these studies rule out a contribution of non-cytolytic
mechanisms for cccDNA elimination, the key step in
resolving a hepadnavirus infection, nor do they deal with
the possibility that cell curing and cell death are competing
pathways for virus elimination, with cell death predominat-
ing during resolution of infection.
In the present study, we have attempted to demonstrate
non-cytolytic cell curing and cccDNA elimination, using
adenovirus super-infection during antiviral treatment in
chronically WHV-infected woodchucks. To enhance the
presentation of the cytokines INF-g and TNF-a to the
hepatocyte population, adenovirus super-infection was car-
ried out with vectors expressing either of these two cyto-
kines or, as a control, adenoviruses expressing beta-
galactosidase. In general, we were unable to detect a
response to these vectors at 1 week post-super-infection
that led to a major loss of WHV RI-DNA from the liver,beyond what could be achieved with clevudine alone. The
difference was only about 4-fold, and about 10-fold 6 weeks
later. A more significant qualitative and quantitative re-
sponse occurred at 2 weeks post-super-infection, when the
adaptive immune response to the adenovirus was expected
to peak (Zhou et al., 2000) (Fig. 6). Thus, a plausible
interpretation of our results is that the antiviral effects of
the adenovirus super-infection were mediated in part by the
adaptive response to the presence of this virus in hepato-
cytes, not by the cytokines expressed by these vectors.
A problem in interpreting the effects of the adenovirus
super-infection is that we do not know if adenoviral DNA is
eliminated by the host response exclusively through cell death
or if non-cytocidal pathways also exist. As previously
reported (Yang et al., 1994b; Zhou et al., 2000), the immune
response to super-infection of the liver by Ad-beta-galactosi-
dase peaks about 2 weeks post-super-infection. Expression of
cytokines by the other two vectors may lead to a considerably
more rapid response. Surprisingly, assays for adenovirus 5
DNA in the liver at different times (Table 4) suggest that the
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vectors is much more rapid, with adenoviral DNA mostly
cleared after a week, while the maximum response to WHV
appears to take longer. This result suggests that clearance of
adenovirus DNA, at least, may occur in part through non-
cytocidal pathways that are less active after super-infection
with Ad-beta-galactosidase, the vector that did not express
cytokines. Nonetheless, the overall effect on WHV did not
appear to differ by 6 weeks post-super-infection between the
two sets of vectors.
However, while the current studies did not demonstrate
non-cytolytic curing of the liver via delivery of antiviral
cytokines, such a possibility still remains open. Options to
consider are use of higher numbers of animals, targeting
delivery of adenoviruses to different cell types, increased
doses of adenoviruses, and additional cytokines or combi-
nations of cytokines, beyond those studied here. Therapies
that combine nucleoside analogue treatment with approaches
to modulate the host immune response, would, if successful,
shorten the treatment time and reduce the possibility of
rebound due to breakthrough of drug-resistant viruses.Materials and methods
Woodchucks
Adult woodchucks (Marmota monax) chronically
infected with WHV were purchased from North Eastern
Wildlife (South Plymouth, NY), and housed in the laboratory
animal facility of the Fox Chase Cancer Center (FCCC).
Clevudine (10 mg per kilogram of body weight) was
administered orally once a day (between 6 and 10 am) in
Dyets Woodchuck Control Diet (Dyets, Inc., Bethlehem, PA)
at a concentration of 10 mg/ml. Serum collection and liver
biopsies were carried out as previously described (Kajino et
al., 1994). Three in vivo experiments were performed. In
experiment 1, woodchucks 373f, 375m, and 376f were
treated for 1 week with clevudine, then inoculated intrave-
nously with recombinant adenoviruses and liver biopsy
samples were collected 24 h and 2 weeks after adenovirus
super-infection as shown in Table 1. In experiment 2, wood-
chucks 362f, 369f, 370f, 365 m, 372 m, 359f, 371f, 363 m,
367f, 366m, and 368m were treated with clevudine for a total
of 38 weeks. Adenovirus vectors were inoculated 5 weeks
after the commencement of treatment with clevudine and
liver biopsies were collected at weeks 6, 11 and between 19
and 52 weeks as shown in Table 2. In experiment 3, wood-
chucks 347m, 349m, 351m, 354f and 357m were treated
with clevudine for a total of 13 weeks. Woodchucks were
inoculated with adenovirus vectors 4 weeks after the com-
mencement of clevudine treatment and were biopsied 4
weeks before clevudine treatment and at 2, 6, 13, and 33
weeks, and autopsied from weeks 33 to 65. Adenovirus
particles inoculated intravenously are taken up by the liver
and infect both hepatocytes and endothelial cells.Experiments with woodchucks were reviewed and ap-
proved by the FCCC Institutional Animal Care and Use
Committee.
Construction of recombinant adenoviruses expressing
woodchuck IFN-c and TNF-a
DNA fragments containing the woodchuck IFN-g and
TNF-a cDNA sequences were excised from previously
described plasmids (Guo et al., 2000) after digestion with
HindIII and XbaI, or HindIII and XhoI. Each fragment was
then inserted into pAdTrack-CMV, a shuttle plasmid for the
AdEasy recombinant adenovirus system (He et al., 1998).
The resulting constructs, each containing IFN-g and TNF-a
genes expressed from a CMV IE promoter, were subse-
quently linearized and co-transformed with pAdEasy-1 into
E. coli BJ5183 cells, and the recombinants pAd-Wc-IFN-g
and pAd-Wc-TNF-a were generated via homologous re-
combination. The pAdTrack-CMV plasmid also contains
the green fluorescent protein (GFP) gene cloned down-
stream of the CMV promoter. Recombinant adenoviruses
expressing Wc-IFN-g and Wc-TNF-a (Ad-Wc-IFN-g and
Ad-Wc-TNF-a) were produced following transfection of
pAd-Wc-IFN-g and pAd-Wc-TNF-a into 293 cells. The
recombinant adenovirus particles were subsequently puri-
fied by CsCl density gradient centrifugation (Alan and
Wilson, 1994). The presence of Wc-IFN-g and Wc-TNF-a
genes in the recombinant adenoviruses was confirmed by
Southern blot hybridization. The adenovirus vector express-
ing beta-galactosidase was described previously (Zhou et
al., 2000).
Generation of recombinant baculoviruses expressing WHV
and GFP
The Bac-To-Bac system (GIBCO-BRL, Rockville, MD)
was used to produce recombinant baculoviruses. To generate
a recombinant baculovirus expressing WHV, a transfer
vector was created by excising the SmaI/PvuII fragment of
pUC119CMVWHV in which the WHV pregenome is
expressed from a cytomegalovirus immediate early (CMV
IE) promoter (Seeger and Maragos, 1989), and cloning it into
pFastBacI treated with SnaBI/StuI. Similarly, a recombinant
transfer vector was created for green fluorescent protein
(GFP) by excising the XhoI/EcoRI fragment of pFRED-
G143, containing a GFP gene expressed from a CMV IE
promoter (kindly provided by A. Tong, Fox Chase Cancer
Center), and cloning it into pFastBacI digested with SnaBI/
EcoRI. Each of these transfer vectors were then transformed
into DH10Bac E. coli cells, in which a transposition event
occurred that produced bacmids containing the entire bacu-
lovirus genome harboring either CMV-WHV or CMV-GFP
genes. Subsequently, the purified recombinant bacmids were
each transfected into Sf9 insect cells, and the recombinant
baculo-CMVWHV and baculo-CMVGFP were produced.
Using supernatants from the Sf9 cell transfections as infec-
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ruses were produced by serial amplification in Sf9 cells.
Recombinant baculovirus-mediated WHV replication in
WC-3 cells
WC-3 woodchuck hepatoma cells (Lee et al., 1987) were
seeded at 2 106 per 60-mm dish in culture medium [DME-
F12 + 10% heat-inactivated fetal calf serum (FCS)]. Sixteen
to twenty hours later, culture medium was removed and 1 ml
of baculo-CMVWHV (at a multiplicity of infection (MOI) of
100, as determined on Sf9 cells) was added to each dish in
serum-free medium. Following a 1-h incubation at 37 jC,
with gentle rocking every 15 min, the medium was changed.
Subsequently, conditioned culture media, harvested from
Ad-Wc-IFN-g-, Ad-Wc-TNF-a-, and Ad-beta-galactosi-
dase-infected WC-3 cell cultures were added as indicated
to the baculovirus-infected cells, and incubation continued at
37 jC. These conditioned media were produced by infecting
WC-3 cultures for 24 h with 100 adenovirus particles per cell
of Ad-Wc-IFN-g, Ad-Wc-TNF-a, or Ad-beta-galactosidase.
The adenovirus-containing culture fluids were discarded,
and the cells were washed three times with PBS. The cultures
were re-fed daily with fresh culture media and the culture
fluids were collected from 2 to 7 days post-inoculation. Four
days after baculo-CMVWHV transduction, WC-3 cells were
harvested. As a control, in parallel, baculo-CMVGFP was
used to transduce WC-3 cells at the same MOI. One day
later, the percentage of GFP-positive WC-3 cells were
estimated under a fluorescent microscope. The transduction
efficiency of WC-3 cells was >40%.
Quantitative RT-PCR analysis of woodchuck liver RNA
expression
Quantitative RT-PCR assays using TaqMan chemistry
were developed to detect woodchuck IFN-g (IFN-g;
AF081502), TNF-a (AF082491), glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH; AF232729), (2V-5V) oligoa-
denylate synthetase (2V-5V OAS; AF082498), and T-cell
surface glycoprotein CD8 alpha chain (CD8; AF082499)
mRNAs. PrimerExpress (ABI, Foster City, CA) software
was used to design specific probe/primers set for each
individual genes. Their sequences were: IFN-g set, IFN1:
5V-GAACTCAAGAAAGTGATGAATGATCTG-3V, IFN2:
5V-GACCCCGAATCGAAG ACTGA-3V, IFN Probe:
6FAM-5V-ACCACACTCTACCCTAAG GAAGC-
GAAAAAGG-3V-BHQ1; TNF-a set, TNF1: 5V-AAAAT-
GAAGACAAGGAGCAGCTG-3V, TNF2: 5V-CATGCCA-
TTGGCCAGGA-3V, TNF-a Probe: 6FAM-5V-TGG-
CTAAGTCGTCGTGCC AATGCC-3V-BHQ1; GAPDH set,
GAPDH1: 5V-TGCCATCACTGCTACTCAGAAGA-3V,
GAPDH2: 5V-GCCCCACGG CCATCA-3V, GAPDH Probe:
6FAM-5V-TTTCCCAGAGGGGCCATCCACA-3V-BHQ1;
2V-5VOAS set, OAS1: 5V-GTGGTGAAGGGTGGCTCCT-
3V, OAS2: 5V-GACAACCAG GTCTGCATCAGAC-3V,OAS Probe: 6FAM-5V-AGGCAAAGGCACTACCCT-
CAG AGGCC-3V-BHQ1; CD8 se t , CD8-1 : 5V-
CGCCCTTGGCTGGGA-3V, CD8-2: 5V-TGG TGACAG-
ATGACGGTGATG-3V, CD8 P r obe : 6FAM-5V-
TGCGCGGTCCTTCTGTTG TCACTG-3V-BHQ1.
Total cellular RNA from woodchuck liver biopsy sam-
ples were extracted using Trizol reagent (GIBCO-BRL),
following the manufacturer’s protocol. One microgram of
each total RNA was used in a quantitative RT-PCR reaction
in a 50 Al volume which also contained 1 Master mix and
1 Multiscribe RT/RNase Inhibitor mix (ABI,), 0.9 AM of
each primer, and 0.25 AM probe. Using an ABI SDS7000
instrument (ABI), quantitative RT-PCR was carried out at
48 jC at 30 min for reverse transcription, followed by 10
min at 95 jC for Taq-Gold polymerase activation, and 40
cycles of 95 jC, 15 s and 60 jC, 60 s. As quantitative
standards, for each PCR plate, a serial dilution of known
copy numbers of linearized plasmid containing the respec-
tive gene was used to construct a threshold crossing cycle
vs. copy number (Ct vs. copy number) standard curve. Also,
two dilutions of in vitro transcribed RNA of the respective
gene were used as positive controls, and a no-template
reaction as negative control. The copy number of tested
gene in each reaction was calculated using a program built
into the instrument according to the standard curve.
Analysis of woodchuck liver RNA by RNase protection assay
(RPA)
Total cellular RNA extracted from woodchuck liver biop-
sy samples was also used for RPA for the detection of
woodchuck IFN-g, TNF-a, GAPDH, 2V–5V OAS, CD4,
and CD8 RNA expression as described previously (Guo et
al., 2000). Briefly, the purified anti-sense RNA probes for
woodchuck IFN-g, TNF-a, GAPDH, 2V–5VOAS, CD4, and
CD8, synthesized by in vitro transcription of each linear
plasmid containing the respective genes, were mixed at 2 
105 cpm with 10 Ag of each total RNA. Hybridization of the
anti-sense RNA probe with RNAwas then carried out in 10
Al buffer containing 80% formamide, 100 mM sodium citrate
(pH 6.4), 300mM sodium acetate (pH 6.4), and 1mMEDTA,
heated to 95 jC for 5 min, followed by incubation over night
at 45 jC. Subsequently, single-stranded RNA was digested
by addition of 100 Al of a solution containing 10 Ag/ml
RNase A, 50000 U/ml RNase T1, 10 mM Tris–HCl (pH
7.5), 300 mM NaCl, and 5 mM EDTA at 37 jC for 45 min.
The samples were then purified by proteinase K treatment
and phenol/chloroform extraction, and precipitated with
ethanol. The protected RNAwas then subjected to denaturing
5% polyacrylamide gel electrophoresis, and the signals were
quantified using a Fuji BAS 1000 phosphoimager.
Analysis of WHV DNA and adenovirus vector DNA
WHV DNA in viral nucleocapsids (RI-DNA) and
cccDNA from recombinant baculovirus-transduced WC-3
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(Moraleda et al., 1997). Isolation of total DNA and cccDNA
from woodchuck liver biopsies was done as reported (Jilbert
et al., 1992). Briefly, 0.05–0.1 g of liver tissue was
disrupted with a loose-fitting Dounce homogenizer in 1.5
ml of 10 mM Tris–HCl (pH 7.5) and 10 mM EDTA. The
number of nuclei in each homogenate was determined
following staining of aliquots with ethidium bromide and
counting in a hemocytometer under fluorescent illumina-
tion. Each homogenate was divided into two aliquots, one
for extraction of non-protein bound cccDNA, and the other
for total DNA isolation (Jilbert et al., 1992; Summers et al.,
1990).
Initially, all samples were analyzed by agarose gel
electrophoresis and Southern blot hybridization. Either 10
Ag of total DNA, or the cccDNA extracted from 106 liver
cells, based on nuclear counts, were subjected to electro-
phoresis through a 1.5% agarose gel. Cloned full-length
linear viral DNA was electrophoresed as a control. DNAs
were transferred to a nitrocellulose filter following partial
de-purination and fragmentation with alkali (Wahl et al.,
1979) and hybridized with a 32P-labeled WHV DNA probe
representing the complete genome. Radioactive signals were
quantified using a Fuji phosphoimager (Fuji Corporation,
Japan). The amounts of viral DNA present in the liver
samples was estimated by comparison to the hybridization
control and, for the purpose of copy number estimations, is
presented as equivalents of full-length, double-stranded
WHV DNA. The woodchuck cell was assumed to have a
diploid DNA content of 5 pg.
In addition, total WHV DNA and cccDNAwere analyzed
by qPCR, essentially as described (Summers et al., 2003).
The conditions for qPCR were 3 min at 95 jC, then 40 cycles
of 15 s at 95 jC, 15 s at 55 jC, and 30 s at 72 jC. For total
WHV DNA analyses, two sets of primers were used, specific
for the 5V and 3V ends of the minus strand of WHV DNA,
respectively. In general, higher copy numbers of viral DNA
were detected early in antiviral therapy with clevudine using
the 5Vspecific primer set, probably because of accumulation
of nascent incomplete minus strands. Where the sensitivity
ranges overlapped, the percentage of changes detected with
the 3Vspecific primers more closely followed those detected
by Southern blotting (data not shown). The primer set
specific to the 3Vend of the minus strand was: forward, 5V-
TTAGTATGCTGGCATGAATTAA-3V (2195–2216); re-
verse, 5V-CCATACTCCAAAACTTACTAAAAATTCTT-3V
(2395–2367). The primer set specific for the 5V end of the
minus strand was: forward, 5V-TCAGACGAGTCG-
GATCTCCCTT-3V (1644–1665), reverse, 5V-AAGTCG-
CATGCATTTATGCCTACA-3V (1922 – 1899). Two
different sets of primers were used for detection of cccDNA
with comparable results. For Table 2, the primers were:
forward, 5V-TCAGACGAGTCGGATCTCCCTT-3V (1644–
1665), reverse, 5V-AGCAATGTTCCCTACCTGTTA-3V
(2165–2145). For Table 3, the primers were forward: 5V-
CTAAATTGATAGCTTGGATGAGCTCTAAC-3V (2217–2245); reverse: 5V-AGCAATGTTC CCTACCTGTTA-3V
(2165–2145) (Table 3). The reaction mix was Sybr Green
Supermix (Bio-Rad). Reactions were carried out in a Bio-
Rad iCycler.
For detection of adenovirus type 5 DNA (GenBank:
BK000408) in total liver DNA extracts, qPCR was
carried out as described above. The primers were forward
5V-ACATGTCTGCGGGTTTCTGCATA-3V (35089 –
35111); reverse: 5V-AGCACTGACCGATGTGAATCA-3V
(35335–35315).
Northern blot analysis of WHV RNA
Total cellular RNA from WC-3 cells and woodchuck
liver biopsy samples were extracted using Trizol reagent
(GIBCO-BRL), following the manufacturer’s protocol. Ten
micrograms of each RNA was denatured in 1 M Glyoxal,
3.8 mM sodium phosphate (pH 6.8), 2 mM EDTA, 50%
DMSO by incubation at 50 jC for 20 min. The samples
were then subjected to electrophoresis through a 1% agarose
gel in 10 mM sodium phosphate (pH 6.8) buffer, and the
RNAwas transferred to a Nylon membrane (Hybond N, Life
Technologies, Inc.). Viral RNAs were detected by hybrid-
ization with a 32P-labeled WHV DNA probe, and the
radioactive signals were quantified using a Fuji phosphoim-
ager (Fuji Corporation) and visualized using Kodak O-mat
X-ray film.
Detection of WHV core antigen and nucleic acid-positive
hepatocytes, PCNA-positive hepatocytes, and infiltrates of
CD3-positive cells in liver tissue sections
Biopsy specimens for immunoperoxidase assays and in
situ hybridization were fixed in a 3:1 mixture of ethanol/
glacial acetic acid for 20 min at 4 jC, then overnight at 4 jC
in 70% ethanol, followed by dehydration and embedding in
paraffin wax. Immunoperoxidase staining for WHV core
antigen, proliferating cell nuclear antigen (PCNA), CD3-
positive leukocytes, and in situ hybridization for detection
of WHV nucleic acids were carried out as previously
described (Guo et al., 2000; Jilbert, 2000; Jilbert et al.,
1992; Mason et al., 1998b; Summers et al., 2003).
Histopathology
Histopathology was evaluated using formalin-fixed, he-
matoxylin and eosin-stained liver sections. Liver injury was
graded on a subjective scale with inflammation of portal
tracts and the hepatic parenchyma, and the presence of
apoptotic hepatocytes (total number detected in four arbi-
trarily selected 20 fields) as the major determinants of the
liver injury score. Other factors influencing the degree of
injury included hepatocyte vacuolation, biliary hyperplasia,
and Kupffer cell activation. Scores were as follows: 0, no
evidence of liver injury; +/, scant numbers of inflamma-
tory cells in portal tracts with minimal inflammation in the
Y. Zhu et al. / Virology 327 (2004) 26–40 39liver parenchyma, with 0–1 apoptotic hepatocytes; +1, mild
accumulations of lymphocytes in portal areas and focal
accumulations in the parenchyma, with 1–3 apoptotic
hepatocytes; +2, moderate inflammation of portal tracts
with sites of extension into the terminal distributing vascu-
lature and moderate parencyhmal involvement and three to
five apoptotic hepatocytes; and +3, moderate to extensive
inflammatory infiltrate extending from the portal tract into
adjacent parenchyma accompanied by moderate to exten-
sive parenchymal inflammation with five or more apoptotic
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